TABLE 3.
Association of the signature with clinicopathological characteristics in Pituitary adenoma patients.
| Variables | Training | Test | Entire | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Low risk | High risk | P | Low risk | High risk | P | Low risk | High risk | P | |
| Sex | 1.00 | 0.36 | 0.62 | ||||||
| Female | 8 | 7 | 8 | 11 | 16 | 18 | |||
| Male | 9 | 9 | 9 | 5 | 18 | 14 | |||
| Age | 0.21 | 0.12 | 0.03 | ||||||
| ≤52 | 7 | 11 | 5 | 10 | 12 | 21 | |||
| >52 | 10 | 5 | 12 | 6 | 22 | 11 | |||
| Tumor size classification | 0.50 | 0.40 | 0.70 | ||||||
| Giant | 6 | 3 | 5 | 5 | 11 | 8 | |||
| Macro | 11 | 13 | 12 | 11 | 23 | 24 | |||
| Invasion | 1.00 | 0.21 | 0.43 | ||||||
| No | 6 | 6 | 10 | 5 | 16 | 11 | |||
| Yes | 11 | 10 | 7 | 11 | 18 | 21 | |||
Data were analyzed using the Chi-squared test; p-value < 0.05 was considered to indicate a statistically significant difference.